Search Results 901-910 of 18558 for Prednisone

  1. A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer - Mayo Clinic

    In addition, participants must be either off corticosteroids or on a stable or decreasing dose of prednisone ≤ 10 mg daily (or equivalent) for at least 2 ...

  2. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

    Prednisone or other corticosteroids used for non-lymphomatous conditions will not be considered as prior chemotherapy; A prior/recent short course (< 2 weeks) ...

  3. Chest pain - Doctors and departments - Mayo Clinic

    Pain in the chest has many possible causes — and some of them are serious. Here's why it's so important to see your health care provider about chest pain.

  4. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

    ... prednisone-equivalent for > 14 days, within 6 months of screening. Note: Subjects required to take or who have taken a dose of ≤ 10 mg/day prednisone ...

  5. Ceftolozane/Tazobactam in Pediatric Patients With Nosocomial Pneumonia - Mayo Clinic

    ... prednisone for participants ≤ 20 kg, or > 40 mg of prednisone per day for participants > 20 kg, administered continuously for more than 14 days in the 30 ...

  6. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

    Treatment with a stable oral corticosteroid dose of ≤ 15 mg prednisone/day or equivalent during study screening and treatment phase. Negative pregnancy ...

  7. Phendimetrazine (oral route) - Side effects & dosage - Mayo Clinic

    Phendimetrazine is used for weight reduction in patients with obesity who have not been able to lose weight with diet and exercise alone. This medicine works by ...

  8. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    * Oral corticosteroid (OCS; prednisone or equivalent) background therapy is permitted but not required. For participants taking OCS, the dose must be stable ...

  9. Long-term Safety and Effectiveness Study for Participants with Advanced Tumors who are Currently on Treatment or in Follow-up in a Pembrolizumab Trial - Mayo Clinic

    Phase trial treatment. - Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone ...

  10. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Use of systemic corticosteroids (> 10 mg prednisone or equivalent) within 15 days (except for prophylaxis for radiodiagnostic contrast reactions), or other ...